cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.15468/dl.ra4sn3
title: Occurrence Download

description: A dataset containing 11 species occurrences available in GBIF matching the query:
{
 "and" : [
 "HasCoordinate is true",
 "Geometry POLYGON ((-118.5963 34.86779, -118.5959 34.86795, -118.5955 34.86812, -118.5951 34.86832, -118.5947 34.86853, -118.5943 34.86876, -118.5939 34.869, -118.5936 34.86926, -118.5932 34.86954, -118.5929 34.86983, -118.5926 34.87013, -118.5923 34.87045, -118.5921 34.87078, -118.5918 34.87112, -118.5916 34.87147, -118.5914 34.87182, -118.5913 34.87219, -118.5911 34.87256, -118.591 34.87294, -118.5909 34.87332, -118.5908 34.87371, -118.5908 34.8741, -118.5908 34.87449, -118.5908 34.87488, -118.5909 34.87766, -118.5909 34.87804, -118.591 34.87842, -118.591 34.8788, -118.5911 34.87917, -118.5913 34.87953, -118.5914 34.8799, -118.5916 34.88025, -118.5918 34.8806, -118.592 34.88094, -118.5922 34.88127, -118.5925 34.88159, -118.5927 34.88189, -118.593 34.88219, -118.5933 34.88247, -118.5937 34.88274, -118.594 34.883, -118.5944 34.88324, -118.5947 34.88346, -118.5951 34.88367, -118.5955 34.88386, -118.596 34.88404, -118.5964 34.88419, -118.5968 34.88433, -118.5972 34.88445, -118.5977 34.88455, -118.5981 34.88463, -118.5986 34.8847, -118.6004 34.8849, -118.6036 34.88529, -118.604 34.88533, -118.6045 34.88536, -118.605 34.88537, -118.6055 34.88535, -118.6059 34.88532, -118.6064 34.88526, -118.6068 34.88519, -118.6073 34.8851, -118.6078 34.88498, -118.6082 34.88485, -118.6086 34.8847, -118.6091 34.88453, -118.6095 34.88434, -118.6099 34.88414, -118.6102 34.88391, -118.6106 34.88367, -118.611 34.88342, -118.6113 34.88315, -118.6116 34.88287, -118.6119 34.88257, -118.6122 34.88226, -118.6125 34.88194, -118.6127 34.88161, -118.6129 34.88127, -118.6131 34.88092, -118.6133 34.88056, -118.6135 34.8802, -118.6136 34.87983, -118.6137 34.87945, -118.6138 34.87907, -118.6138 34.87869, -118.6139 34.8783, -118.6139 34.87792, -118.6139 34.87753, -118.6136 34.87389, -118.6135 34.8735, -118.6135 34.87312, -118.6134 34.87274, -118.6133 34.87237, -118.6131 34.872, -118.613 34.87164, -118.6128 34.87128, -118.6126 34.87094, -118.6123 34.8706, -118.6121 34.87027, -118.6118 34.86996, -118.6115 34.86966, -118.6112 34.86937, -118.6109 34.86909, -118.6105 34.86883, -118.6102 34.86858, -118.6098 34.86835, -118.6094 34.86813, -118.609 34.86793, -118.6086 34.86775, -118.6082 34.86759, -118.6077 34.86745, -118.6073 34.86732, -118.6069 34.86722, -118.6064 34.86713, -118.6039 34.86672, -118.6034 34.86665, -118.603 34.8666, -118.6025 34.86657, -118.602 34.86657, -118.6015 34.86659, -118.601 34.86662, -118.6006 34.86668, -118.6001 34.86676, -118.5996 34.86686, -118.5992 34.86697, -118.5968 34.86765, -118.5963 34.86779))",
 {
 "not" : {
 "TaxonKey" : [
 "is Plantae"
 ]
 }
 },
 {
 "not" : {
 "TaxonKey" : [
 "is Aves"
 ]
 }
 },
 "Year is greater than or equal to 1926",
 "Year is less than or equal to 2025"
 ]
}

 The dataset includes 11 records from 1 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0053572-251120083545085/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.13130/rd_unimi/uoloji/8ag19y
title: Marzo_1936_Pagina_039.jpg

description: Bulletin of 1936/03/10
DOI: 10.6084/m9.figshare.30580742
title: Harnessing coumarin-thio(seleno)cyanate conjugates: potent <i>In vivo</i> antiproliferative agents targeting carbonic anhydrases

description: We synthesised coumarin-based derivatives bearing thio- and selenocyanates to selectively inhibit tumour-associated carbonic anhydrases (CAs) IX and XII and to exert antiproliferative effects on tumour cells. Structural variations included chalcogen atom type (S, Se), substitutions at C-3/C-4, and tether length at C-7 of the coumarin core. Thiocyanates <b>4</b> and <b>7b</b> showed potent CA IX/XII inhibition (<i>K</i><sub>i</sub> = 17.9–27.4 nM) with &gt;5000-fold selectivity over off-target isoforms (CAs I and II). Selenocyanate <b>8a</b> exhibited strong antiproliferative activity (GI<sub>50</sub> = 0.78–2.6 µM) across six human solid tumour cell lines. Mechanistic studies revealed a cytostatic effect <i>via</i> cell cycle arrest and reduced mitotic progression. <i>In vivo</i> assays in <i>Caenorhabditis elegans</i> confirmed selective cytostatic action of selenocyanate <b>8c</b>, reducing tumorous germline size without affecting healthy tissues at therapeutic doses.
DOI: 10.6084/m9.figshare.30580742.v1
title: Harnessing coumarin-thio(seleno)cyanate conjugates: potent <i>In vivo</i> antiproliferative agents targeting carbonic anhydrases

description: We synthesised coumarin-based derivatives bearing thio- and selenocyanates to selectively inhibit tumour-associated carbonic anhydrases (CAs) IX and XII and to exert antiproliferative effects on tumour cells. Structural variations included chalcogen atom type (S, Se), substitutions at C-3/C-4, and tether length at C-7 of the coumarin core. Thiocyanates <b>4</b> and <b>7b</b> showed potent CA IX/XII inhibition (<i>K</i><sub>i</sub> = 17.9–27.4 nM) with &gt;5000-fold selectivity over off-target isoforms (CAs I and II). Selenocyanate <b>8a</b> exhibited strong antiproliferative activity (GI<sub>50</sub> = 0.78–2.6 µM) across six human solid tumour cell lines. Mechanistic studies revealed a cytostatic effect <i>via</i> cell cycle arrest and reduced mitotic progression. <i>In vivo</i> assays in <i>Caenorhabditis elegans</i> confirmed selective cytostatic action of selenocyanate <b>8c</b>, reducing tumorous germline size without affecting healthy tissues at therapeutic doses.
DOI: 10.13130/rd_unimi/uoloji/1rp9vx
title: Marzo_1936_Pagina_040.jpg

description: Bulletin of 1936/03/10
DOI: 10.13130/rd_unimi/uoloji/0zskgy
title: Marzo_1936_Pagina_041.jpg

description: Bulletin of 1936/03/11
DOI: 10.13130/rd_unimi/uoloji/rmzuow
title: Marzo_1936_Pagina_043.jpg

description: Bulletin of 1936/03/11
DOI: 10.13130/rd_unimi/uoloji/xluhzr
title: Marzo_1936_Pagina_042.jpg

description: Bulletin of 1936/03/11
DOI: 10.13130/rd_unimi/uoloji/cayexg
title: Marzo_1936_Pagina_044.jpg

description: Bulletin of 1936/03/11
DOI: 10.13130/rd_unimi/uoloji/hiktyn
title: Marzo_1936_Pagina_045.jpg

description: Bulletin of 1936/03/12
DOI: 10.6084/m9.figshare.30672911
title: Phytochemical constituents of <i>Hydrangea macrophylla</i> var. <i>acuminata</i> leaves and their inhibitory activity against PTP1B and α-glucosidase

description: This study presents the first comprehensive phytochemical analysis of <i>Hydrangea macrophylla</i> var. <i>acuminata</i> leaves, resulting in the isolation of 41 secondary metabolites, including four new compounds: one phenolic (<b>3</b>) and three bis-iridoid glycosides (<b>30</b>–<b>32</b>). The inhibitory activities of these compounds against PTP1B and α-glucosidase were evaluated. Among them, compound <b>12</b> exhibited the most potent dual inhibition, with IC<sub>50</sub> values of 8.0 ± 1.1 µM for PTP1B and 3.4 ± 0.2 µM for α-glucosidase. Compounds <b>8</b> and <b>9</b> showed notable α-glucosidase inhibitory activity, with IC<sub>50</sub> values of 21.9 ± 0.4 µM and 43.8 ± 2.1 µM, respectively. Enzyme kinetics and molecular docking studies revealed their inhibition mechanisms and binding interactions. This study is the first detailed phytochemical investigation of <i>H. macrophylla</i> var. <i>acuminata</i> and highlights its potential as a natural source of PTP1B and α-glucosidase inhibitors. These findings underscore the plant’s promise for developing antidiabetic agents targeting PTP1B and α-glucosidase.
DOI: 10.6084/m9.figshare.30672911.v1
title: Phytochemical constituents of <i>Hydrangea macrophylla</i> var. <i>acuminata</i> leaves and their inhibitory activity against PTP1B and α-glucosidase

description: This study presents the first comprehensive phytochemical analysis of <i>Hydrangea macrophylla</i> var. <i>acuminata</i> leaves, resulting in the isolation of 41 secondary metabolites, including four new compounds: one phenolic (<b>3</b>) and three bis-iridoid glycosides (<b>30</b>–<b>32</b>). The inhibitory activities of these compounds against PTP1B and α-glucosidase were evaluated. Among them, compound <b>12</b> exhibited the most potent dual inhibition, with IC<sub>50</sub> values of 8.0 ± 1.1 µM for PTP1B and 3.4 ± 0.2 µM for α-glucosidase. Compounds <b>8</b> and <b>9</b> showed notable α-glucosidase inhibitory activity, with IC<sub>50</sub> values of 21.9 ± 0.4 µM and 43.8 ± 2.1 µM, respectively. Enzyme kinetics and molecular docking studies revealed their inhibition mechanisms and binding interactions. This study is the first detailed phytochemical investigation of <i>H. macrophylla</i> var. <i>acuminata</i> and highlights its potential as a natural source of PTP1B and α-glucosidase inhibitors. These findings underscore the plant’s promise for developing antidiabetic agents targeting PTP1B and α-glucosidase.
DOI: 10.13130/rd_unimi/uoloji/flspmt
title: Marzo_1936_Pagina_046.jpg

description: Bulletin of 1936/03/12
DOI: 10.13130/rd_unimi/uoloji/pfzn65
title: Marzo_1936_Pagina_047.jpg

description: Bulletin of 1936/03/12
DOI: 10.13130/rd_unimi/uoloji/zvfdpj
title: Marzo_1936_Pagina_048.jpg

description: Bulletin of 1936/03/12
DOI: 10.13130/rd_unimi/uoloji/9jqg5x
title: Marzo_1936_Pagina_050.jpg

description: Bulletin of 1936/03/13
DOI: 10.13130/rd_unimi/uoloji/m3v8am
title: Marzo_1936_Pagina_049.jpg

description: Bulletin of 1936/03/13
DOI: 10.6084/m9.figshare.29931001.v1
title: Development of triaryl antimicrobials by scaffold hopping from an aminopropanol hit targeting bacterial RNA polymerase-NusG interactions

description: Bacterial RNA polymerase (RNAP) requires the NusG factor to facilitate transcription, with the RNAP clamp-helix domain (CH) serving as the primary binding site for NusG and representing a promising target for antimicrobial intervention. In previous work, we unprecedentedly developed a pharmacophore model based on key clamp-helix residues (R270, R278, R281) at RNAP CH essential for NusG binding, which led to the identification of a hit compound exhibiting modest antimicrobial activity against <i>Streptococcus pneumoniae</i>. In this study, we designed a new class of triaryl inhibitors via scaffold hopping, substituting the linear structure of the hit compound with a benzene ring. Antimicrobial testing showed that several newly synthesised lead compounds achieved the minimum inhibitory concentration of 1 µg/mL against drug-resistant <i>S. pneumoniae</i>, superior to some marketed antibiotics. The following inhibitory and cell-based assays demonstrated the potential of these triaryl compounds as promising candidates for further development as novel antimicrobial agents.
DOI: 10.13130/rd_unimi/uoloji/zzgeek
title: Marzo_1936_Pagina_051.jpg

description: Bulletin of 1936/03/13
DOI: 10.6084/m9.figshare.29931001
title: Development of triaryl antimicrobials by scaffold hopping from an aminopropanol hit targeting bacterial RNA polymerase-NusG interactions

description: Bacterial RNA polymerase (RNAP) requires the NusG factor to facilitate transcription, with the RNAP clamp-helix domain (CH) serving as the primary binding site for NusG and representing a promising target for antimicrobial intervention. In previous work, we unprecedentedly developed a pharmacophore model based on key clamp-helix residues (R270, R278, R281) at RNAP CH essential for NusG binding, which led to the identification of a hit compound exhibiting modest antimicrobial activity against <i>Streptococcus pneumoniae</i>. In this study, we designed a new class of triaryl inhibitors via scaffold hopping, substituting the linear structure of the hit compound with a benzene ring. Antimicrobial testing showed that several newly synthesised lead compounds achieved the minimum inhibitory concentration of 1 µg/mL against drug-resistant <i>S. pneumoniae</i>, superior to some marketed antibiotics. The following inhibitory and cell-based assays demonstrated the potential of these triaryl compounds as promising candidates for further development as novel antimicrobial agents.
DOI: 10.13130/rd_unimi/uoloji/rx9n26
title: Marzo_1936_Pagina_052.jpg

description: Bulletin of 1936/03/13
DOI: 10.13130/rd_unimi/uoloji/mrxovc
title: Marzo_1936_Pagina_053.jpg

description: Bulletin of 1936/03/14
DOI: 10.13130/rd_unimi/uoloji/pqxxmc
title: Marzo_1936_Pagina_054.jpg

description: Bulletin of 1936/03/14
DOI: 10.6084/m9.figshare.29371468
title: Identification of potent inhibitors of potential VEGFR2: a graph neural network-based virtual screening and <i>in vitro</i> study

description: VEGFR2 is a transmembrane tyrosine kinase receptor expressed on vascular endothelial cells and is closely associated with tumour cell growth. A comparison of traditional Chinese medicines and natural products with existing VEGFR2 inhibitors revealed that the former exhibited superior anticancer properties while concomitantly showing a reduced incidence of adverse effects. We proposed a novel strategy for screening potential candidates targeting VEGFR2 in a Chinese medicine monomer database using a combination of AI deep learning and structure-based drug design. The graph neural network served as the final predictive model to evaluate the molecular activities within the database, resulting in the selection of six candidate compounds. Kinase inhibition assays showed that the three compounds exhibited significant inhibition of VEGFR2. Molecular docking and molecular dynamics simulations further demonstrated the stability of their binding to VEGFR2. This study identified three compounds that effectively inhibited VEGFR2, making them promising candidates in cancer treatment.
DOI: 10.6084/m9.figshare.29371468.v1
title: Identification of potent inhibitors of potential VEGFR2: a graph neural network-based virtual screening and <i>in vitro</i> study

description: VEGFR2 is a transmembrane tyrosine kinase receptor expressed on vascular endothelial cells and is closely associated with tumour cell growth. A comparison of traditional Chinese medicines and natural products with existing VEGFR2 inhibitors revealed that the former exhibited superior anticancer properties while concomitantly showing a reduced incidence of adverse effects. We proposed a novel strategy for screening potential candidates targeting VEGFR2 in a Chinese medicine monomer database using a combination of AI deep learning and structure-based drug design. The graph neural network served as the final predictive model to evaluate the molecular activities within the database, resulting in the selection of six candidate compounds. Kinase inhibition assays showed that the three compounds exhibited significant inhibition of VEGFR2. Molecular docking and molecular dynamics simulations further demonstrated the stability of their binding to VEGFR2. This study identified three compounds that effectively inhibited VEGFR2, making them promising candidates in cancer treatment.
DOI: 10.13130/rd_unimi/uoloji/91m0kn
title: Marzo_1936_Pagina_055.jpg

description: Bulletin of 1936/03/14
DOI: 10.13130/rd_unimi/uoloji/dolxlu
title: Marzo_1936_Pagina_056.jpg

description: Bulletin of 1936/03/14
DOI: 10.13130/rd_unimi/uoloji/solhmb
title: Marzo_1936_Pagina_058.jpg

description: Bulletin of 1936/03/15
DOI: 10.13130/rd_unimi/uoloji/xfaqmd
title: Marzo_1936_Pagina_057.jpg

description: Bulletin of 1936/03/15
DOI: 10.6084/m9.figshare.28359259
title: Chemical composition, antioxidant activities, and enzyme inhibitory effects of <i>Lespedeza bicolour</i> Turcz. essential oil

description: <i>Lespedeza bicolour</i> Turcz. is a traditional medicinal plant with a wide range of ethnomedicinal values. The main components of <i>L. bicolour</i> essential oil (EO) were β-pinene (15.41%), β-phellandrene (12.43%), and caryophyllene (7.79%). The EO of <i>L. bicolour</i> showed antioxidant activity against ABTS radical and DPPH radical with an IC<sub>50</sub> value of 0.69 ± 0.03 mg/mL and 10.44 ± 2.09 mg/mL, respectively. The FRAP antioxidant value was 81.96 ± 6.17 μmol/g. The EO had activities against acetylcholinesterase, α-glucosidase, and β-lactamase with IC<sub>50</sub> values of 309.30 ± 11.16 μg/mL, 360.47 ± 35.67 μg/mL, and 27.54 ± 1.21 μg/mL, respectively. Molecular docking showed methyl dehydroabietate docked well with all tested enzymes. Sclareol and (+)-borneol acetate showed the strongest binding affinity to α-glucosidase and β-lactamase, respectively. The present study provides a direction for searching enzyme inhibitors for three tested enzymes and shows <i>L. bicolour</i> EO possesses the potential to treat a series of diseases.
DOI: 10.6084/m9.figshare.28359259.v1
title: Chemical composition, antioxidant activities, and enzyme inhibitory effects of <i>Lespedeza bicolour</i> Turcz. essential oil

description: <i>Lespedeza bicolour</i> Turcz. is a traditional medicinal plant with a wide range of ethnomedicinal values. The main components of <i>L. bicolour</i> essential oil (EO) were β-pinene (15.41%), β-phellandrene (12.43%), and caryophyllene (7.79%). The EO of <i>L. bicolour</i> showed antioxidant activity against ABTS radical and DPPH radical with an IC<sub>50</sub> value of 0.69 ± 0.03 mg/mL and 10.44 ± 2.09 mg/mL, respectively. The FRAP antioxidant value was 81.96 ± 6.17 μmol/g. The EO had activities against acetylcholinesterase, α-glucosidase, and β-lactamase with IC<sub>50</sub> values of 309.30 ± 11.16 μg/mL, 360.47 ± 35.67 μg/mL, and 27.54 ± 1.21 μg/mL, respectively. Molecular docking showed methyl dehydroabietate docked well with all tested enzymes. Sclareol and (+)-borneol acetate showed the strongest binding affinity to α-glucosidase and β-lactamase, respectively. The present study provides a direction for searching enzyme inhibitors for three tested enzymes and shows <i>L. bicolour</i> EO possesses the potential to treat a series of diseases.
DOI: 10.13130/rd_unimi/uoloji/hswykk
title: Marzo_1936_Pagina_059.jpg

description: Bulletin of 1936/03/15
DOI: 10.13130/rd_unimi/uoloji/srxabt
title: Marzo_1936_Pagina_060.jpg

description: Bulletin of 1936/03/15
DOI: 10.13130/rd_unimi/uoloji/mao3bb
title: Marzo_1936_Pagina_062.jpg

description: Bulletin of 1936/03/16
DOI: 10.13130/rd_unimi/uoloji/shei9c
title: Marzo_1936_Pagina_061.jpg

description: Bulletin of 1936/03/16
DOI: 10.13130/rd_unimi/uoloji/0a0pip
title: Marzo_1936_Pagina_063.jpg

description: Bulletin of 1936/03/16
DOI: 10.13130/rd_unimi/uoloji/zo1glg
title: Marzo_1936_Pagina_064.jpg

description: Bulletin of 1936/03/16
DOI: 10.13130/rd_unimi/uoloji/fjclma
title: Marzo_1936_Pagina_066.jpg

description: Bulletin of 1936/03/17
DOI: 10.13130/rd_unimi/uoloji/jpsm1p
title: Marzo_1936_Pagina_065.jpg

description: Bulletin of 1936/03/17
DOI: 10.13130/rd_unimi/uoloji/3zjm5y
title: Marzo_1936_Pagina_067.jpg

description: Bulletin of 1936/03/17
DOI: 10.13130/rd_unimi/uoloji/dyxwdf
title: Marzo_1936_Pagina_068.jpg

description: Bulletin of 1936/03/17
DOI: 10.25574/26578
title: Chandra X-ray Observatory ObsId 26578

description: A Test to Establish that SS 433 is an Ultraluminous X-ray Source
DOI: 10.13130/rd_unimi/uoloji/dwwr2h
title: Marzo_1936_Pagina_070.jpg

description: Bulletin of 1936/03/18
DOI: 10.13130/rd_unimi/uoloji/layqyj
title: Marzo_1936_Pagina_069.jpg

description: Bulletin of 1936/03/18
DOI: 10.13130/rd_unimi/uoloji/5r6qsn
title: Marzo_1936_Pagina_071.jpg

description: Bulletin of 1936/03/18
DOI: 10.13130/rd_unimi/uoloji/mqz7fz
title: Marzo_1936_Pagina_072.jpg

description: Bulletin of 1936/03/18
DOI: 10.13130/rd_unimi/uoloji/8wsvcl
title: Marzo_1936_Pagina_074.jpg

description: Bulletin of 1936/03/19
DOI: 10.13130/rd_unimi/uoloji/nsvefo
title: Marzo_1936_Pagina_073.jpg

description: Bulletin of 1936/03/19
DOI: 10.13130/rd_unimi/uoloji/asdeap
title: Marzo_1936_Pagina_075.jpg

description: Bulletin of 1936/03/19
DOI: 10.13130/rd_unimi/uoloji/zvhuvw
title: Marzo_1936_Pagina_076.jpg

description: Bulletin of 1936/03/19
DOI: 10.13130/rd_unimi/uoloji/bcsimu
title: Marzo_1936_Pagina_078.jpg

description: Bulletin of 1936/03/20
DOI: 10.13130/rd_unimi/uoloji/pdjufx
title: Marzo_1936_Pagina_077.jpg

description: Bulletin of 1936/03/20
DOI: 10.13130/rd_unimi/uoloji/cdnqgx
title: Marzo_1936_Pagina_079.jpg

description: Bulletin of 1936/03/20
DOI: 10.13130/rd_unimi/uoloji/fkgbed
title: Marzo_1936_Pagina_080.jpg

description: Bulletin of 1936/03/20
DOI: 10.13130/rd_unimi/uoloji/qo09oh
title: Marzo_1936_Pagina_081.jpg

description: Bulletin of 1936/03/21
DOI: 10.13130/rd_unimi/uoloji/zskbl7
title: Marzo_1936_Pagina_082.jpg

description: Bulletin of 1936/03/21
DOI: 10.13130/rd_unimi/uoloji/a7joky
title: Marzo_1936_Pagina_083.jpg

description: Bulletin of 1936/03/21
DOI: 10.13130/rd_unimi/uoloji/8v8kf3
title: Marzo_1936_Pagina_085.jpg

description: Bulletin of 1936/03/22
DOI: 10.13130/rd_unimi/uoloji/eawe14
title: Marzo_1936_Pagina_084.jpg

description: Bulletin of 1936/03/21
DOI: 10.13130/rd_unimi/uoloji/ked5m0
title: Marzo_1936_Pagina_086.jpg

description: Bulletin of 1936/03/22
DOI: 10.13130/rd_unimi/uoloji/k2bghv
title: Marzo_1936_Pagina_087.jpg

description: Bulletin of 1936/03/22
DOI: 10.13130/rd_unimi/uoloji/jhix5x
title: Marzo_1936_Pagina_088.jpg

description: Bulletin of 1936/03/22
DOI: 10.13130/rd_unimi/uoloji/scr7y6
title: Marzo_1936_Pagina_089.jpg

description: Bulletin of 1936/03/23
DOI: 10.13130/rd_unimi/uoloji/amtuow
title: Marzo_1936_Pagina_090.jpg

description: Bulletin of 1936/03/23
DOI: 10.13130/rd_unimi/uoloji/ke8div
title: Marzo_1936_Pagina_092.jpg

description: Bulletin of 1936/03/23
DOI: 10.13130/rd_unimi/uoloji/nnqkpu
title: Marzo_1936_Pagina_091.jpg

description: Bulletin of 1936/03/23
DOI: 10.13130/rd_unimi/uoloji/dzbmxi
title: Marzo_1936_Pagina_093.jpg

description: Bulletin of 1936/03/24
DOI: 10.13130/rd_unimi/uoloji/dojlwa
title: Marzo_1936_Pagina_094.jpg

description: Bulletin of 1936/03/24
DOI: 10.13130/rd_unimi/uoloji/b54wx8
title: Marzo_1936_Pagina_096.jpg

description: Bulletin of 1936/03/24
DOI: 10.13130/rd_unimi/uoloji/xica4u
title: Marzo_1936_Pagina_095.jpg

description: Bulletin of 1936/03/24
DOI: 10.13130/rd_unimi/uoloji/na6zak
title: Marzo_1936_Pagina_097.jpg

description: Bulletin of 1936/03/25
DOI: 10.13130/rd_unimi/uoloji/o97rdj
title: Marzo_1936_Pagina_098.jpg

description: Bulletin of 1936/03/25
DOI: 10.13130/rd_unimi/uoloji/6cramc
title: Marzo_1936_Pagina_100.jpg

description: Bulletin of 1936/03/25
DOI: 10.13130/rd_unimi/uoloji/youdpy
title: Marzo_1936_Pagina_099.jpg

description: Bulletin of 1936/03/25
DOI: 10.13130/rd_unimi/uoloji/zzhg4u
title: Marzo_1936_Pagina_101.jpg

description: Bulletin of 1936/03/26
DOI: 10.13130/rd_unimi/uoloji/dc6krz
title: Marzo_1936_Pagina_102.jpg

description: Bulletin of 1936/03/26
DOI: 10.13130/rd_unimi/uoloji/f7xdbx
title: Marzo_1936_Pagina_104.jpg

description: Bulletin of 1936/03/26
DOI: 10.13130/rd_unimi/uoloji/q8udcu
title: Marzo_1936_Pagina_103.jpg

description: Bulletin of 1936/03/26
DOI: 10.13130/rd_unimi/uoloji/qpjpnc
title: Marzo_1936_Pagina_105.jpg

description: Bulletin of 1936/03/27
DOI: 10.13130/rd_unimi/uoloji/7v6zam
title: Marzo_1936_Pagina_106.jpg

description: Bulletin of 1936/03/27
DOI: 10.13130/rd_unimi/uoloji/wrptiw
title: Marzo_1936_Pagina_107.jpg

description: Bulletin of 1936/03/27
DOI: 10.13130/rd_unimi/uoloji/xgrzml
title: Marzo_1936_Pagina_108.jpg

description: Bulletin of 1936/03/27
DOI: 10.13130/rd_unimi/uoloji/oykuco
title: Marzo_1936_Pagina_109.jpg

description: Bulletin of 1936/03/28
DOI: 10.13130/rd_unimi/uoloji/qede9w
title: Marzo_1936_Pagina_110.jpg

description: Bulletin of 1936/03/28
DOI: 10.13130/rd_unimi/uoloji/kila9g
title: Marzo_1936_Pagina_111.jpg

description: Bulletin of 1936/03/28
DOI: 10.13130/rd_unimi/uoloji/zbaqbp
title: Marzo_1936_Pagina_112.jpg

description: Bulletin of 1936/03/28
DOI: 10.13130/rd_unimi/uoloji/zhxdbl
title: Marzo_1936_Pagina_113.jpg

description: Bulletin of 1936/03/29
DOI: 10.13130/rd_unimi/uoloji/fmrdlp
title: Marzo_1936_Pagina_114.jpg

description: Bulletin of 1936/03/29
DOI: 10.13130/rd_unimi/uoloji/dxz3m3
title: Marzo_1936_Pagina_115.jpg

description: Bulletin of 1936/03/29
DOI: 10.13130/rd_unimi/uoloji/p1gdjm
title: Marzo_1936_Pagina_117.jpg

description: Bulletin of 1936/03/30
DOI: 10.13130/rd_unimi/uoloji/uou5kr
title: Marzo_1936_Pagina_116.jpg

description: Bulletin of 1936/03/29